In response to LPS treatment in ALI mice, alveolar macrophages (AMs) undergo M1 activation, characterized by the expression and secretion of pro-inflammatory factors, such as TNF-α, IL-1β, and inducible nitric oxide synthase (iNOS) (10). The gene discussed is IL1B; the disease is acute respiratory distress syndrome.